Showing results (1621-1630 of 1,835) with videos related to

Sort By:
Pageof 184
Onkologie|February 1, 1990
Randomized clinical trial comparing mitoxantrone with epirubicin and with doxorubicin, each combined with cyclophosphamide in the first-line treatment of patients with metastatic breast cancerE Heidemann, B Steinke, J Hartlapp, et al.
Onkologie|February 1, 1990
Sequential versus alternating chemotherapy for high-grade non-Hodgkin's lymphomas: preliminary results of a phase III multicentre trialH Köppler, K H Pflüger, I Eschenbach, et al.
Onkologie|February 1, 1990
Recombinant human granulocyte-macrophage colony-stimulating factor and low-dose cytosine-arabinoside in the treatment of patients with myelodysplastic syndromes. A phase II studyK Höffken, F Overkamp, J Stirbu, et al.
Onkologie|September 22, 2011
Cancer patients and the Internet: a survey of the 'Quality of Life' Working Groups of the Arbeitsgemeinschaft für Internistische Onkologie and the Nord-Ostdeutsche Gesellschaft für Gynäkologische OnkologieDeniz Gencer, Felix Tauchert, Nina Keilhauer, et al.
Onkologie|September 22, 2011
Pulmonary toxicity with oxaliplatin and capecitabine/5-Fluorouracil chemotherapy: a case report and review of the literatureAndrew K Chan, Bok A Choo, John Glaholm
Onkologie|October 12, 2011
A Lentiviral CXCR4 overexpression and knockdown model in colorectal cancer cell lines reveals plerixafor-dependent suppression of SDF-1α-induced migration and invasionDoreen Heckmann, Stephanie Laufs, Patrick Maier, et al.
Onkologie|October 12, 2011
Endoscopic ultrasound staging and guided fine needle aspiration biopsy in patients with resectable pancreatic malignancies: a single-center prospective experienceIoannis Karoumpalis, Panagiotis Sigalas, Charitini Salla, et al.
Onkologie|October 12, 2011
Successful treatment of a patient with HER2-positive metastatic gastric cancer with third-line combination therapy with irinotecan, 5-fluorouracil, leucovorin and trastuzumab (FOLFIRI-T)Florian Weissinger, Marc Reymond, Klaus Dumke, et al.
Onkologie|February 8, 2012
Effectiveness of erlotinib in advanced non-small cell lung cancer in cases of gefitinib resistance after treatment of more than 6 monthsHaruhiro Saito, Shuji Murakami, Tetsuro Kondo, et al.
Onkologie|February 8, 2012
Metronomic oral cyclophosphamide in patients with advanced solid tumorsPeter Bojko, Gudrun Schimmel, Daniel Bosse, et al.
Pageof 184